REPROCELL News

  • Company: REPROCELL, Inc. (JASDAQ Company code: 4978)
  • Representative: Chikafumi Yokoyama, PhD
  • Contact: info-us@reprocell.com

“ReproHP Medium,” a highly functional culture fluid for human primary liver cells developed in conjunction with the National Cancer Center, is set to go on sale in December this year.

Continue reading →

Hepatocytes, iPSC


Announcement: FY 2014-2015 Grant (Additional) for Manufacturing, Commerce, and Service Innovation Has Been Awarded to “Prototype Development of a Liver Cell Kit Derived From Functional Human Induced Pluripotent Stem Cells for Applications in Drug Discovery”

  • Company: REPROCELL, Inc.
  • Representative: President and Representative Director Shuji Yokoyama (Company code: 4978)
  • Point of contact: Business Management Director Daigo Obita (Telephone: 045-475-3887)

We are pleased to announce that one of our projects, “Prototype Development of a Liver Cell Kit Derived From Functional Human Induced Pluripotent Stem (iPS) Cells for Applications in Drug Discovery” (hereafter, “the project”), has been selected as a recipient of Grant for Manufacturing, Commerce, and Service Innovation additionally allocated for FY 2014-2015.

Continue reading →

Hepatocytes